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Evidence from many directions supports the
view that keratinization and cholesterol metabo-
lism in the epidermis are intimately connected.
As early as the 1890's Liebreich (1) believed that
the orderly formation of an epidermal horny
layer requires an orderly arrangement of lipids.
More than a half century ago, on the basis of
crude chemical and histochemical findings which
indicated a much higher percentage of csterified
cholesterol in the horny layer than in the total
epidermis, Unna and Golodetz (2) first claimed
that free cholesterol undergoes cstcrification
during kcratinization of epidermal cells in man.
In 1932 Kooyman (3) carefully re-examined and
confirmed this finding using more refined tech-
nics on acid-separated palmar and plantar epi-
dermis where sebaceous glands do not compli-
cate the situation.
More recently Swanbcck (4), using x-ray dif-
fraction technics, found evidence that the 250 A
protein fibrils of normal human horny layer are
surrounded by a lipid layer about 80 A thick.
Furthermore, he and Thyresson (5) showed that
this lipid layer is apparently altered under condi-
tions of pathological kcratinization such as exist
in psoriasis. Still further, it is recent history that
clinically striking disturbances of keratinization
have occurred as a complicating side effect from
the dangerous drug triparanol (MER-29) which
blocks the reduction of the 24—25 double bond of
the cholesterol precursors, dcsmosterol as well as
lanosterol (6, 7).
In 1950, Rothman (8) reported that the ratio
of esterified to free cholesterol in the skin surface
lipids obtained from non-involved skin areas in
psoriatic individuals was pathologically low, and
on this basis postulated that predisposition to
psoriasis might be associated with a fundamental
genetically determined deficiency in the choles-
terol esterifying ability of the keratinizing epider-
mis. Wheatlcy (9) later confirmed Rothman's
findings, and he also noted that there was a de-
crease in unsaturated fatty acids in skin surface
lipids obtained from normal-appearing skin areas
of psoriatics. In 1962, Whcatlcy (9) attempted to
interpret these findings by postulating that the
sebaceous glands produce mainly esterified choles-
terol, while the epidermis produces mainly free
cholesterol, some of which is esterified during the
process of keratinization. In psoriasis, he felt
that there was a decreased output of schum, and
an increased output of epidermal lipids, with the
net result that the proportion of esterified choles-
terol in the surface lipids of both the involved
and uninvolved skin was lowered.
Simple non-specific esterases on the skin sur-
face as reviewed by Montagna (10), especially
at the mouths of schaccous glands and along the
piliary canal, have been amply demonstrated.
Stcigleder (11) in particular made a detailed
study of surface simple esterases, and even
demonstrated such csterasc in skin surface wip-
ings made with filter paper. He considered as its
possible sources sebum, sweat, kcratinizing
cpithelial cells, and the skin's microbial flora, and
viewed the skin as having a protective "csterase
mantle."
In view of the apparently active involvement
of the skin's horny layer and surface in ester
biochemistry, the current studies were under-
taken to demonstrate directly cholesterol esteri-
fying activity on the skin surface, and then to
compare normal and non-involved psoriatic skin
in regard to this activity.
EXPERJMENTAL
As indicated in Table I, 11 normal and 9 pso-
riatic Caucasiaa volunteers served as experi-
mental subjects. Fifteen-hundredths to 0.17 mg
of palmitic acid containing 1 Mc of carboxyl C'4-
labelt dissolved in 2 ml of petroleum ether was
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TABLE I
Pertinent data on experimental tolnnteers
Manifestations of Psoriasis at
Time of Study
Lesions chiefly on elbows
and knees affecting less
than 10% of skin surface.
Psoriasis on scalp and
pitting of nails.
Lesions chiefly on hands and
arms covering less than
15% of skin snrface; nails
affected.
Chiefly intertriginous, el-
bow and lower extremity
lesions affecting less than
10% of skin snrface; nails
affected.
Guttate psoriasis affecting
less than 10% of skin
snrface.
Chiefly intertriginous, sac-
ral and elbow lesions
affecting less than 10% of
skin surface.
Psoriasis only on palms
and fingers.
Lesions on scalp, hands
and left leg affecting less
than 10% of skin surface.
Psoriasis of nails.
All eleven of the subsequent subjects were
normal males with ages as follows: 27, 33, 24, 32,
33, 25, 55, 29, 30, 50, 28.
pipetted dropwise evenly onto each of 2 demar-
cated areas of lesion-free skin approximately
300 cm° in area on the back of each subject. After
2.5 hours, during which time the outlined areas
were freely exposed to the air while the subjects
rested, each 300 cm2 area was repeatedly thor-
oughly wiped with petroleum ether-soaked cotton
balls, until no further radioactivity could be
detected on the skin surface with a Ceiger, Eber-
line end-window counter, Model E-500B.
The total lipids removed from each experimental
area were recovered from the cotton balls by 7
successive extractions in a separatory funnel with
100 ml portions of petroleum ether. These 7 petro-
leum ether extracts were pooled and washed suc-
cessively with two 100- and two 50-ml portions of
0.06 N sodium hydroxide in 50 per cent ethanol
in order to remove the free fatty acids from the
neutral fat fraction (12). These 4 washings were
combined and counterwashed with two 50-ml
portions of petroleum ether, and the counter
washings were combined with the original petro-
leum ether pool of neutral fats. This total neutral
fat fraction was then dried under a stream of
nitrogen.
The free fatty acid containing aqueous-alcohol
phase was neutralized with 6 N sulfuric acid, and
washed with successive two 100-mi and four 50-mi
portions of petroleum ether to recover the non-
esterified palmitic acid. This fraction gave a
negative Liebermann-Burchard reaction.
Chromatographic separation of the neutral fat
fraction was carried out on a silicic acid column
essentially according to the method of Mukherjee
(13).
The neutral fat fraction, together with 10 mg of
non-labeled cholesterol palmitate as carrier, was
dissolved in 30 ml of pentane* and poured onto a
1 )< 12.5 cm lJnicii column (activated silicic acid,
100—200 mesh) .t The column was then eluted with
50 ml each of 1,4, 10, and 25 per cent ethyl ether in
pentane, and 100 per cent ethyl ether. Each of
these 5 eluates was collected in 15, 10, 10, and 15
ml serial subfractions off the column. An aliquot
of each subfraction was tested for the presence of
cholesterol and its esters by the modified Schoen-
heimer-Sperry method described by Windhorst
and Foster (14) which is based on the Liebermann-
Burchard color reaction. Optical densities for the
determination of the free cholesterol and the
cholesterol palmitate were read at 625 m on a
Beckman DU spectrophotometer. Table II sum-
marizes the chromatographic scheme and indicates
some pertinent characteristics of the various
fractions collected.
The isolated cholesterol ester containing frac-
tions were further directly identified by drying
1-ml aliquots of the chromatographic cuts under
a stream of nitrogen and taking up the residue in
3 to 5 ml of petroleum ether. Saponification was
then carried out by adding a few drops of 10 per
cent potassium hydroxide in 95 per cent ethanol
and refiuxing for 2 hours. After cooling, the liber-
ated cholesterol was separated from the saponified
fatty acids by extraction with petroleum ether
as already has been generally described. The fatty
acid containing aqueous fraction was negative on
Liebermann-Burehard testing, whereas the cho-
lesterol containing petroleum ether fraction was
positive. On measurement in a liquid seintillator,
only the fatty acid fraction contained radio-
activity.
Radioaetivities in all chromatographic fractions
were measured in a Packard Tri-Carb Liquid
Scintillation Counter. A 1-mi aliquot was taken
from each coHected fraction, dried under a stream
of nitrogen and taken up in 15 ml of scintillation
fluid consisting of 4 gm PPO (2,5-Diphenyioxa-
zoie) and 0.1 gm POPOP (1-4 bis-2-(5-Phenyi-
oxazoiyi)-Benzene) per liter of toiuene.
In 4 normal voiunteers, as an additional eontroi,
the entire study was repeated following a regimen
* Chromatoquaiity Reagent, Matheson, Cole-
man and Bell Company.
Ciarkson Chemical Company, Williamsport,
Pennsyivania.
Sex AgeSub-ject
1
2
3
4
5
6
7
8
9
Maie
Male
Male
Male
Maie
Female
Male
Femaie
Male
60
16
72
44
31
54
60
46
30
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of twice daily bathing and local applications of an
ointment consisting of 6 per cent ammoniated
mercury, 2.4 per cent salicylic acid, and 6 per
cent Doak's tar distillate in aquaphor for 3 days
to areas comparable to those which may have
been similarly treated in some of the psoriatics
just prior to the study. Also because of the possi-
bility that the microbial flora of the skin surface
might be implicated in cholesterol esterification,
the study was repeated in 1 normal volunteer
after pre-treatment of the test area with a neomy-
ci bacitracin, polymyxin-containing ointment(Neosporin ointment) for 1 day. Still further con-
trols included 2 patients with minor eczematous
dermatitis of the hands and feet, and 1 patient
with an eczematized patch of dermatitis about a
stasic ulcer.
RESULTS
Tables III and IV indicate the percentages of
the total recovered radioactivity in the choles-
terol ester and glycerol ester fractions of the
neutral fats obtained from the skin test areas in
each normal and psoriatic subject.
In the 11 normal adults, from 1 to 25 per cent
of the total radioactivity recovered was in the
cholesterol ester fraction, the median being 4.9
per cent. In the 9 psoriatics, only from 0.2 to 2.8
per cent of the recovered radioactivity was in the
cholesterol esters, the median being 0.5 per cent.
In general, there is an approximately ten-fold
difference in cholesterol esterifying ability be-
tween the two groups. Table V indicates similar
data for the additional control subjects tested.
Results in all cases show skin surface cholesterol
esterifying ability clearly in the normal range.
As concerns glycerol esterifying ability of the
skin surface, no clear differences arc apparent
between the normal, control, and psoriatic sub-
jects although there is possibly an equivocal
trend toward diminished such activity in the
psoriatics.
D150U5510N
The observed markedly deficient cholesterol
esterifying ability of the skin surface in lesion-
free areas of psoriatic subjects could be based
either on deficiency of the enzyme system re-
quired for cholesterol estcrification, or on the
presence of some inhibitor of this system. In
either case, as suggested many years ago by
Rothman, this deficiency is probably genetically
determined and may well prove to be funda-
mental in determining predisposition to psoria-
sis, especially in view of the relationships between
TABLE II
Chromatographic scheme and pertinent
characteristics of coltected fractions
rraction
No. Eluent volume Characteristics
Sal
1 1% ether in
pentane
15) Negative Lieber-
mann-Burchard
test
2 4% ether in
pentane
10
15
is)
10
10)
Contains all choles-
terol palmitate
Negative Lieber-
mann-Burchard
test
3 10% ether in
pentane
is)
i5
10)
101
isf
Contains all glyc-
eryl tripalmitate
Negative Lieber-
mann-Burchard
test
4
5
25% ether in
pentane
ether
15
iof
101
1sf
is)
101
101
is)
Negative Lieber-
mann-Burchard
test
Contains all free
cholesterol
Negative Lieber-
mann-Burchard
test
keratinization and epidermal cholesterol metabo-
lism. Additional studios arc under way on the
cholesterol esterifying ability of the skin surface
in the kindred of psoriatics in order to obtain
further information on the genetic dependence
of this finding. Several speculations might be
worth consideration at this point. For example,
epidermal cholesterol synthesis in psoriatics may
to a greater extent follow the pathway found by
Bloch and others in liver (15) involving free
zymosterol and desmosterol as precursors of free
cholesterol, rather than the so-called Kandutoh-
Russell (16), probably normally predominant
epidermal pathway as first postulated by Wheat-
Icy (17, 18), involving esterified lathosterol and
7-dehydrocholesterol as immediate precursors of
esterified cholesterol (7). Reinertson's and Wheat-
ley's (19) finding of deficient 7-dehydrocholesterol
in the epidermal lipids of non-involved skin in
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TABLE III
Experimental results in normal subjects
TABLE IV
Experimental results in psoriatic subjects
Counts in Counts in Total Counts in Total Counts in
Subject Total Counts CholesterolEsters GlycerolEsters CholesterolEsters Av. GlycerolEsters Av.
1
2
527,068
938,160
1,102,550
1,041,250
5,685
12,345
2,730
4,400
2,530
8,345
18,700
13,735
per crest
1.1
1.3
0.2
0.4
1.2
0.3
per cent
0.5
0.9
1.7
1.3
0.7
1.5
3 849,544
306,248
1,360
690
3,240
1,270
0.2
0.2
0.2 0.4
0.4
0.4
4 947,097
931,263
4,320
4,565
8,675
14,075
0.5
0.5
0.5 0.9
1.5
1.2
5 861,000
801,720
5,000
5,825
610
480
0.6
0.7
0.6 0.08
0.06
0.07
6 552,640
777,120
4,260
2,310
1,050
510
0.8
0.3
0.5 0.2
0.1
0.1
7 1,370,000
1,823,000
16,350
25,080
1,250
1,250
1.2
1.4
1.3 0.1
0.1
0.1
8 679,400
808,600
2,480
4,155
375
435
0.4
0.5
0.4 0.06
0.06
0.06
9 808,945
1,023,300
18,780
27,780
14,170
15,070
2.3
2.7
2.5 1.8
1.5
1.6
Subject
10
11
12
13
14
15
16
17
18
19
20
Total Counts
1,245,122
1,187,581
928,600
840,600
1,116,225
825,500
951,000
900,800
928,800
838,600
1,173,120
838,370
849,300
779,900
1,223,300
959,360
844,200
966,000
750,500
987,200
559,000
575,900
Counts in
Cholesterol
Esters
52,362
34,078
29,220
24,040
35,360
6,810
139,785
111,345
90,510
43,845
138,875
94,370
39,900
40,050
247,100
238,335
122,655
161,355
21,395
22,530
28,050
25,350
I TotalCounts in Counts inGlycerol CholesterolEsters Esters
per cent
5,477 4.2
2,650 2.9
5,370 3.2
7,650 2.9
25,680 3.2
23,360 0.8
8,800 14.7
4,650 1.3
11,645 9.8
6,580 5.2
9,430 11.8
7,105 11.3
9,340 4.7
5,215 5.1
10,940 20.0
9,685 24.8
13,170 14.5
8,370 16.7
4,980 2.9
5,355 2.3
13,615 5.0
5,330 4.4
Av.
3.5
3.0
2.0
8.0
7.5
11.5
4.9
22.4
15.6
2.6
4.7
Total
Counts in
Glycerol
Esters
per cent
0.4
0.2
0.6
0.9
2.3
2.8
0.93
0.5
1.3
0.8
0.8
0.9
1.1
0.7
0.9
1.0
1.6
0.9
0.7
0.6
2.4
0.9
Av.
0.3
0.7
2.5
0.7
1.0
0.8
0.9
0.9
1.2
0.6
1.6
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TABLE V
Experimental results in additional control subjects
Subject Total Counts
Counts in
Cholesterol
Esters
Counts in
Glycerol
Esters
Total
Counts in I AvCholesterol
Esters
Total
Counts in Av.GlycerolEsters
Normal subjects after antipsoriatic treatment regimen
11
10
16
18
neosporin
10
1,698,000
1,898,400
1,011,840
857,560
1,365,400
1,315,000
1,018,050
1,169,520
1,476,000
39,225
55,710
123,940
63,700
66,016
74,840
46,310
38,560
42,368
9,090
8,200
7,410
4,290
5,520
3,730
5,180
3,465
15,321
per cent
2.3
2.9
12.3
7.4
4.8
5.7
4.6
3.3
2.9
2.6
9.8
5.2
3.9
per cent
0.54
0.44
0.7
0.5
0.4
0.3
0.5
0.3
1.0
0.5
0.6
0.3
0.4
Subjects with minor eczematous dermatitis
21
22
23
930,600
860,090
657,500
731,625
881,430
1,058,860
15,155
27,780
41,740
83,220
72,350
33,440
395
695
7,170
10,980
36,572
9,582
1.7
3.2
6.3
11.4
8.2
3.2
2.4
8.8
5.7
0.1
0.1
1.1
0.8
4.2
0.9
0.1
0.9
2.5
psoriatics is consistent with this view, as is
Wheatley's (9) finding of a deficiency of un-
saturated fatty acids in the surface lipids ob-
tained from non-involved skin of psoriatics.
Cholesterol and its precursors are preferentially
esterified with unsaturated fatty acids, and if
such esterification is deficient, a smaller amount
of unsaturated fatty acids would be carried to
the skin surface during keratinization. Further-
more, in order to obtain the normal 80 A lipid
coat around keratin protofibrils suggested by
Swanbeck's observations (4), esterified choles-
terol would probably be necessary and hence
abnormal keratinization might be expected in
the absence of sufficient cholesterol esters during
keratin protofibril formation. If this be the basic
defect in psoriasis, an obvious approach to devis-
ing rational therapy would be directed at cor-
recting the deficiency in epidermal sterol esterifi-
cation. Perhaps even directly applying esters of
cholesterol and its Kandutch-Russell precursors
might be helpful.
The accelerated epidermopoiesis and its many
consequences which are so characteristic of
psoriasis could be a phenomenon secondary to
defective keratin formation and loss of some nor-
mal feed-back suppression of epidermal cell divi-
sion and differentiation. A still further speculation
might even possibly relate the speeded epidermo-
poiesis to allergic so-called autosensitization to
abnormal antigens arising during the defective
keratinization process.
Under any circumstance one would expect that
the epidermis in psoriatics, because of its deficient
cholesterol esterifying ability, might not be able
to form sufficient normal aggregated keratin
under conditions of increased demand for keratin
production as occurs wherever epidermopoiesis is
accelerated from any cause. The predilectional
localization of psoriasis to areas of physiologically
most active epidermopoiesis as pointed out by
Kuta and Neumann (20) as well as the Koebner
phenomenon could be accounted for in this way.
Conversely, the beneficial effect on psoriatic
lesions of any agent or procedure which inhibits
epidermopoiesis could also easily be understood.
SUMMARY
The cholesterol esterifying ability of the skin
surface in a series of psoriatic and non-psoriatic
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volunteers was examined. One mierocuric
amounts of C14-labeled palmitie acid were applied
to approximately 300 cm2 areas of normal ap-
pearing skin on the hack. After 2.5 hours, surface
lipids were recovered from the treated areas by
wiping with ether-soaked cotton balls. These
lipids were separated chromatographically and
the radioactivity of the cholesterol esters was
measured by liquid scintillation counting. In
psoriatic individuals only about one-tenth as
much radioactivity was found in this fraction as
in the controls.
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